King Lee

680 total citations
12 papers, 530 citations indexed

About

King Lee is a scholar working on Hardware and Architecture, Cancer Research and Computer Networks and Communications. According to data from OpenAlex, King Lee has authored 12 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hardware and Architecture, 4 papers in Cancer Research and 3 papers in Computer Networks and Communications. Recurrent topics in King Lee's work include Parallel Computing and Optimization Techniques (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Interconnection Networks and Systems (2 papers). King Lee is often cited by papers focused on Parallel Computing and Optimization Techniques (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Interconnection Networks and Systems (2 papers). King Lee collaborates with scholars based in United States, New Zealand and Canada. King Lee's co-authors include Robert M. Rodriguez, W. C. Moffatt, Harriette J. Kahn, Reuben Baumal, Paul S. Thorner, Robert Shorr, David A. Bailey, Horst D. Simon, Zuzana Zachar and Shawn D. Stuart and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

King Lee

12 papers receiving 509 citations

Peers

King Lee

MB

CR

ONCOL

SURGE

PFM

Vincent Bertholet Belgium

John Boyer United States

Yueh‐Chun Lee Taiwan

Takeshi Ozeki Japan

Michele Martinelli Italy

Silke Radetzki Germany

Tejal Patel United States

Pleumjit Boonyaphiphat Thailand

Jie Ji China

Rahul Mannan India

Vincent Bertholet Belgium

King Lee

389 ×1.7

MB

95 ×0.5

CR

262 ×1.7

ONCOL

66 ×1.0

SURGE

21 ×0.4

PFM

Citations per year, relative to King Lee King Lee (= 1×) peers Vincent Bertholet

Countries citing papers authored by King Lee

Since Specialization

Citations

This map shows the geographic impact of King Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by King Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites King Lee more than expected).

Fields of papers citing papers by King Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by King Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by King Lee. The network helps show where King Lee may publish in the future.

Co-authorship network of co-authors of King Lee

This figure shows the co-authorship network connecting the top 25 collaborators of King Lee. A scholar is included among the top collaborators of King Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with King Lee. King Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Bruckner, Howard W., et al.. (2017). Broad safety impact of high-dose ascorbic acid and induction chemotherapy for high-risk pancreatic cancer.. Journal of Clinical Oncology. 35(15_suppl). e15711–e15711. 7 indexed citations

2.

Pardee, Timothy S., King Lee, John Luddy, et al.. (2014). A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies. Clinical Cancer Research. 20(20). 5255–5264. 91 indexed citations

3.

Pardee, Timothy S., King Lee, John Luddy, et al.. (2013). A Phase I Study Of The Safety, Efficacy and Pharmacokinetics Of The First In Class Pyruvate Dehydrogenase Complex Inhibitor Cpi-613 In Patients With Advanced Hematologic Malignancies. Blood. 122(21). 486–486. 1 indexed citations

4.

Lee, King, et al.. (2011). Long-Term Stable Disease of Stage IV Pancreatic Neuroendocrine Tumors and Without Significant Adverse Effect by CPI-613, an Investigational Novel Anti-Cancer Agent. 1(3). 137–145. 9 indexed citations

5.

Zachar, Zuzana, James F. Marecek, Sunita Gupta, et al.. (2011). Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. Journal of Molecular Medicine. 89(11). 1137–1148. 170 indexed citations

6.

Feun, Lynn G., Manuel Modiano, King Lee, et al.. (2002). Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule. Cancer Chemotherapy and Pharmacology. 50(3). 223–229. 108 indexed citations

7.

Lee, King & Paul Kutler. (1998). Achieving High Performance on the i860 Microprocessor. NASA Technical Reports Server (NASA). 1 indexed citations

8.

Lee, King. (1992). ACHIEVING HIGH PERFORMANCE ON THE i860™ MICROPROCESSOR WITH NASPACK SUBROUTINES. 4(4). 269–287. 4 indexed citations

9.

Lee, King. (1992). ON THE FLOATING POINT PERFORMANCE OF THE i860™ MICROPROCESSOR. 4(4). 251–267. 8 indexed citations

10.

Bailey, David A., King Lee, & Horst D. Simon. (1991). Using Strassen's algorithm to accelerate the solution of linear systems. The Journal of Supercomputing. 4(4). 357–371. 40 indexed citations

11.

Thorner, Paul S., Harriette J. Kahn, Reuben Baumal, King Lee, & W. C. Moffatt. (1986). Malignant myoepithelioma of the breast: An immunohistochemical study by light and electron microscopy. Cancer. 57(4). 745–750. 72 indexed citations

12.

Lee, King. (1966). A mixed problem for hyperbolic equations with time-dependent domain. Journal of Mathematical Analysis and Applications. 16(3). 455–471. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact